5 November 2026

Next article →

Drugs Rules 1945 Amendments for Substandard Drugs

Why in news

  • Union Health Ministry proposed amendments to the Drugs Rules, 1945, to mandate immediate suspension of manufacturing licences for drugs declared Not of Standard Quality (NSQ) on critical parameters.

Key terms

Not of Standard Quality (NSQ)

Official designation for a drug sample failing testing standards set out in pharmacopoeias or regulations.

Corrective and Preventive Action (CAPA)

Systematic process implemented by manufacturers to eliminate root causes of non-conformity or quality failures.

Drugs and Cosmetics Act, 1940

Parent legislation governing the import, manufacture, distribution, and sale of drugs and cosmetics in India.

CDSCO

National regulatory body for Indian pharmaceuticals and medical devices under the Ministry of Health and Family Welfare.

What is the parent framework?

  • Drugs Rules, 1945, framed under the Drugs and Cosmetics Act, 1940, regulate the manufacture, sale, and distribution of drugs in India.
  • Administered by the Central Drugs Standard Control Organisation (CDSCO) and State Licensing Authorities.

Key changes proposed

  • Before: Licence suspension or cancellation required lengthier regulatory procedures, including issuing show-cause notices first, creating a time gap during which production could continue.
  • After: Immediate suspension of manufacturing licences upon detection of NSQ status in critical quality parameters such as assay, dissolution, sterility, impurities, or related substances.
  • Restoration of suspended licences will only be permitted after verified Corrective and Preventive Action (CAPA) by manufacturers.

Why it matters

  • Prevents continued production and market circulation of defective drugs immediately upon laboratory failure.
  • Strengthens state-level regulatory coordination and enforced accountability in pharmaceutical manufacturing.

Prelims facts

  • Drugs Rules, 1945 are framed under the authority of the Drugs and Cosmetics Act, 1940.

Mains discussion

  • Evaluate regulatory gaps in India's drug quality oversight and the role of swift executive powers in mitigating public health risks.

Source: PIB

समान विषय · पिछले पेपर

UPSC ने यह पहले भी पूछा है

ये पिछले वर्षों के प्रश्न उसी विषय पर हैं। अभ्यास के लिए खोलें।

  1. 2026 · Q9 · GS III · 10 marks

    Explain how fake news and disinformation pose threat to Internal Security and Public Order in Indian context? In this regard, discuss salient features of amendments in respect of Information Technology (Intermediatory Guidelines and Digital Media Ethics Code) Rules 2021.

    उत्तर देखें →

  2. 2023 · Q34 · General Studies · 2 marks

    In India, which one of the following Constitutional Amendments was widely believed to be enacted to overcome the judicial interpretations of the Fundamental Rights?

    उत्तर देखें →

  3. 2020 · Q2 · GS II · 10 marks

    "Recent amendments to the Right to information Act will have profound impact on the autonomy and independence of the Information Commission". Discuss.

    उत्तर देखें →

← All Prelims + Mains notes for 5 November 2026

PDF
Daily news · PIB · quiz — Free